TRV GP Ii, LLC, 10% Owner at Jounce Therapeutics, Inc. (JNCE), sold 552,520 shares at $8.00 ($4.4M) on 2021-05-25, disclosed to the SEC on 2021-05-27.
Open-market sale of $4.4M JNCE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |